Miach Orthopaedics, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Miach Orthopaedics, Inc. - overview

Established

2016

Location

Westborough, MA, US

Primary Industry

Medical Devices & Equipment

About

Founded in 2016 and based in Massachusetts, US, Miach Orthopaedics, Inc. operates as a developer of a surgical implant for connective tissue repair in ACL injury cases. In March 2024, Miach Orthopaedics, Inc. raised USD 20 million led by the Major League Soccer Players Association, SV Health Investors, and Aperture Venture Partners, including Amzak Health, Smith+Nephew, DSM Venturing, Sectoral Asset Management, Endeavour Vision, and the NFL Players Association.


The series B funding values Miach Orthopaedics, Inc. at USD 94. 71 million post-money. As of 2024, the company is led by its CEO, Patrick McBrayer.


  The company’s primary product, the BEAR® Implant, offers an approach to ACL (anterior cruciate ligament) restoration. This implant is designed to bridge the torn ends of the ACL with the patient’s own blood, promoting natural healing and potentially reducing recovery time compared to traditional methods. The organization plans to use the March 2024 funding to expand its commercial BEAR implant and further market growth in clinical-related activities.


Current Investors

DSM Venturing, NFL Players Association, Amzak Capital Management

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Supplies

Website

www.miachortho.com/

Verticals

Manufacturing

Company Stage

Series B

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.